EXTRACELL BIOTECHNOLOGIES (Private limited company)
EXTRACELL BIOTECHNOLOGIES is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0804.532.945. It was founded on 03-08-2023. Its registered office is in Liège. Its main activity is: Scientific research and development. Its annual accounts for 2025 report equity of € -8 397 and a loss of € 1 898. Addrly gives it a financial health grade of E, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for 2 of its last 3 financial years.
Information last updated on 07-10-2026.
Company information
Key figures of EXTRACELL BIOTECHNOLOGIES
| 2025 | 2024 | 2023 | |
|---|---|---|---|
Profit / lossiWhat the period earned after taxes. A negative amount is a loss. | € -1 898+86 % | € -14 044-472 % | € -2 455 |
EquityiWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company. | € -8 397-29 % | € -6 499 | € 7 545 |
Total assetsiEverything the company owns. Equal to total equity and liabilities, which says how it is financed. | € 485+61 % | € 301-96 % | € 7 545 |
Gross marginiSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else. | € -1 852+87 % | € -14 019-477 % | € -2 431 |
Employees (FTE)iAverage number of workers over the period, in full-time equivalents. | - | - | - |
Financial estimate
Similar companies
Other companies in the same activity in Liège.
| Company | Town |
|---|---|
| V.T. MONITOR | 4031 Liège |
| MICROBELCAPS | 4031 Liège |
| IMCYSE | 4031 Liège |
| SPIAPS | 4031 Liège |
| constellr Belgium | 4031 Liège |
| LaCAR MDx technologies | 4031 Liège |
| OSIVAX Belgique | 4031 Liège |
| LAETITIA TARDIF CONSULTING | 4031 Liège |
Frequently asked questions
Is EXTRACELL BIOTECHNOLOGIES still active? Yes. The Crossroads Bank for Enterprises lists EXTRACELL BIOTECHNOLOGIES as active.
What is the VAT number of EXTRACELL BIOTECHNOLOGIES? The VAT number of EXTRACELL BIOTECHNOLOGIES is BE 0804.532.945.
When was EXTRACELL BIOTECHNOLOGIES founded? EXTRACELL BIOTECHNOLOGIES was founded on 03-08-2023.
What is the address of EXTRACELL BIOTECHNOLOGIES? The current registered office of EXTRACELL BIOTECHNOLOGIES is Avenue du Pré-Aily 4, 4031 Liège.
When did EXTRACELL BIOTECHNOLOGIES last file annual accounts? The latest annual accounts of EXTRACELL BIOTECHNOLOGIES were filed on 30-07-2026.
Does EXTRACELL BIOTECHNOLOGIES file its annual accounts on time? EXTRACELL BIOTECHNOLOGIES filed its annual accounts within the legal deadline for 2 of its last 3 financial years. Late: 2023.
Is EXTRACELL BIOTECHNOLOGIES financially healthy? Addrly gives EXTRACELL BIOTECHNOLOGIES a financial health grade of E, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.
Is EXTRACELL BIOTECHNOLOGIES profitable? The annual accounts of EXTRACELL BIOTECHNOLOGIES for 2025 show a loss of € 1 898.
What is the equity of EXTRACELL BIOTECHNOLOGIES? The equity of EXTRACELL BIOTECHNOLOGIES was € -8 397 at the close of the 2025 financial year.
Who are the directors of EXTRACELL BIOTECHNOLOGIES? The annual accounts of EXTRACELL BIOTECHNOLOGIES record 2 mandates. The names, roles and dates are visible with a free account.
Can EXTRACELL BIOTECHNOLOGIES receive Peppol e-invoices? Yes. EXTRACELL BIOTECHNOLOGIES is registered on the Peppol network and can receive structured electronic invoices.
What does EXTRACELL BIOTECHNOLOGIES do? The main activity of EXTRACELL BIOTECHNOLOGIES is: Scientific research and development.